LPS signal transduction: the picture is becoming more complex

Sander H Diks1, Dick J Richel, Maikel P Peppelenbosch

  • 1Laboratory for Experimental Internal Medicine, G2-105, Academic Medical Center, University of Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, The Netherlands. S.H.Diks@amc.uva.nl

Insights

Lipopolysaccharide (LPS) triggers septic shock and mortality. New therapies targeting LPS immune response pathways are needed due to rising antibiotic resistance, offering hope for effective treatments.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Lipopolysaccharide (LPS) is a key trigger of septic shock and a major cause of post-operative mortality.
  • Conventional antibiotic therapies are becoming less effective against infections leading to sepsis, particularly with the rise of antibiotic-resistant strains like MRSA.
  • Novel treatment strategies for LPS-mediated septic shock are urgently required.

Purpose of the Study:

  • To review the molecular mechanisms of LPS recognition and immune response initiation.
  • To discuss recent insights into LPS-dependent signal transduction pathways, including receptor clustering and signalosome activation.
  • To highlight how understanding these pathways can aid in developing new therapeutic approaches.

Main Methods:

  • Literature review of molecular mechanisms in LPS recognition.
  • Analysis of recent research on immune response initiation.
  • Synthesis of findings on signal transduction pathways, receptor clustering, and signalosome activation.

Main Results:

  • Detailed overview of molecular pathways involved in LPS recognition and immune activation.
  • Elucidation of recent advancements in understanding LPS signal transduction, receptor dynamics, and signalosome assembly.
  • Identification of critical molecular targets for therapeutic intervention.

Conclusions:

  • A deeper understanding of LPS-dependent signal transduction is crucial for developing novel, rational therapies.
  • Targeting specific molecular mechanisms in the LPS recognition and signaling cascade offers a promising avenue for treating septic shock.
  • This review provides a foundation for future research aimed at combating LPS-induced sepsis and improving patient outcomes.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...